Entity Central Index Key
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to intercompany amounts.
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in specified foreign income tax contingency.
Income tax reconciliation nondeductible lobbying expenses.
Cover [Abstract]
Entity Registrant Name
Entity Registrant Name
Entity Central Index Key
Entity Central Index Key
Document Type
Document Type
Document Period End Date
Document Period End Date
Amendment Flag
Amendment Flag
Current Fiscal Year End Date
Current Fiscal Year End Date
Entity Small Business
Entity Small Business
Entity Emerging Growth Company
Entity Emerging Growth Company
ICFR Auditor Attestation Flag
Icfr Auditor Attestation Flag
Entity Shell Company
Entity Shell Company
Entity Current Reporting Status
Entity Current Reporting Status
Entity Interactive Data Current
Entity Interactive Data Current
Entity Filer Category
Entity Filer Category
Entity Public Float
Entity Public Float
Entity Common Stock, Shares Outstanding
Entity Common Stock Shares Outstanding
Document Fiscal Year Focus
Document Fiscal Year Focus
Document Fiscal Period Focus
Document Fiscal Period Focus
Trading Symbol
Trading Symbol
Entity Well-known Seasoned Issuer
Entity Well Known Seasoned Issuer
Entity Voluntary Filers
Entity Voluntary Filers
Entity File Number
Entity File Number
Entity Incorporation, State or Country Code
Entity Incorporation State Country Code
Entity Tax Identification Number
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address Address Line1
Entity Address, Address Line Two
Entity Address Address Line2
Entity Address, City or Town
Entity Address City Or Town
Entity Address, Country
Entity Address Country
Entity Address, Postal Zip Code
Entity Address Postal Zip Code
City Area Code
City Area Code
Local Phone Number
Local Phone Number
Document Annual Report
Document Annual Report
Document Transition Report
Document Transition Report
Title of 12(b) Security
Security12b Title
Security Exchange Name
Security Exchange Name
Auditor Firm ID
Auditor Firm Id
Auditor Name
Auditor Name
Auditor Location
Auditor Location
Carrying value as of the balance sheet date of obligations relating to sales discounts, allowances and reserves.
Statement Of Financial Position [Abstract]
ASSETS
Assets [Abstract]
CURRENT ASSETS:
Assets Current [Abstract]
Cash and cash equivalents
Cash And Cash Equivalents At Carrying Value
Investments—short-term
Available For Sale Securities Debt Securities Current
Receivables, net
Receivables Net Current
Inventory
Inventory Net
Contract assets
Contract With Customer Asset Net Current
Prepaid expenses and other current assets
Prepaid Expense And Other Assets Current
Total current assets
Assets Current
PROPERTY, PLANT AND EQUIPMENT, NET
Property Plant And Equipment Net
INVESTMENTS—LONG-TERM
Long Term Investments
RIGHT-OF-USE ASSETS
Operating Lease Right Of Use Asset
INTANGIBLE ASSETS, NET
Finite Lived Intangible Assets Net
GOODWILL
Goodwill
DEFERRED TAX ASSETS
Deferred Income Tax Assets Net
OTHER ASSETS
Other Assets Noncurrent
TOTAL ASSETS
Assets
LIABILITIES AND SHAREHOLDERS’ EQUITY
Liabilities And Stockholders Equity [Abstract]
CURRENT LIABILITIES:
Liabilities Current [Abstract]
Accounts payable and accrued expenses
Accounts Payable And Accrued Liabilities Current
Accrued sales discounts, allowances and reserves
Accrued Sales Discounts Allowances And Reserves
Operating lease liabilities—short-term
Operating Lease Liability Current
Contract liabilities—short-term
Contract With Customer Liability Current
Current portion of long-term debt
Long Term Debt Current
Total current liabilities
Liabilities Current
LONG-TERM DEBT
Long Term Debt Noncurrent
OPERATING LEASE LIABILITIES—LONG-TERM
Operating Lease Liability Noncurrent
OTHER LONG-TERM LIABILITIES
Other Liabilities Noncurrent
Total liabilities
Liabilities
COMMITMENTS AND CONTINGENT LIABILITIES (Note 17)
Commitments And Contingencies
SHAREHOLDERS’ EQUITY:
Stockholders Equity [Abstract]
Preferred shares, par value, $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at December 31, 2022 and 2021, respectively
Preferred Stock Value
Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 168,951,193 and 165,790,549 shares issued; 164,377,009 and 161,937,327 shares outstanding at December 31, 2022 and 2021, respectively
Common Stock Value
Treasury shares, at cost (4,574,184 and 3,853,222 shares at December 31, 2022 and 2021, respectively)
Treasury Stock Common Value
Additional paid-in capital
Additional Paid In Capital Common Stock
Accumulated other comprehensive loss
Accumulated Other Comprehensive Income Loss Net Of Tax
Accumulated deficit
Retained Earnings Accumulated Deficit
Total shareholders’ equity
Stockholders Equity
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
Liabilities And Stockholders Equity
Preferred stock shares, par value (in dollars per share)
Preferred Stock Par Or Stated Value Per Share
Preferred stock shares, authorized
Preferred Stock Shares Authorized
Preferred stock shares, issued
Preferred Stock Shares Issued
Preferred stock shares, outstanding
Preferred Stock Shares Outstanding
Ordinary shares, par value (in dollars per share)
Common Stock Par Or Stated Value Per Share
Ordinary shares, shares authorized
Common Stock Shares Authorized
Ordinary shares, shares issued
Common Stock Shares Issued
Ordinary shares, shares outstanding
Common Stock Shares Outstanding
Treasury shares
Treasury Stock Common Shares
Income Statement [Abstract]
Statement [Table]
Statement [Table]
Product and Service
Product Or Service [Axis]
Product and Service
Products And Services [Domain]
Product sales, net
Product [Member]
Article or substance produced by labor or machinery, and royalties.
Manufacturing and royalty revenues
Manufactured Product And Royalty [Member]
License revenue
License [Member]
Relating to research and development.
Research and development revenue
Research And Development [Member]
Statement [Line Items]
Statement [Line Items]
REVENUES:
Disaggregation Of Revenue [Abstract]
Total revenues
Revenue From Contract With Customer Excluding Assessed Tax
EXPENSES:
Costs And Expenses [Abstract]
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)
Cost Of Goods And Services Sold
Research and development
Research And Development Expense
Selling, general and administrative
Selling General And Administrative Expense
Amortization of acquired intangible assets
Amortization Of Intangible Assets
Total expenses
Costs And Expenses
OPERATING LOSS
Operating Income Loss
OTHER (EXPENSE) INCOME, NET:
Nonoperating Income Expense [Abstract]
Interest income
Investment Income Interest
Interest expense
Interest Expense
Change in the fair value of contingent consideration
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
Other income, net
Other Nonoperating Income Expense
Total other (expense) income, net
Nonoperating Income Expense
LOSS BEFORE INCOME TAXES
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
INCOME TAX (BENEFIT) PROVISION
Income Tax Expense Benefit
NET LOSS
Net Income Loss
LOSS PER ORDINARY SHARE:
Earnings Per Share [Abstract]
Basic
Earnings Per Share Basic
Diluted
Earnings Per Share Diluted
WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES OUTSTANDING:
Weighted Average Number Of Shares Outstanding [Abstract]
Basic
Weighted Average Number Of Shares Outstanding Basic
Diluted
Weighted Average Number Of Diluted Shares Outstanding
COMPREHENSIVE LOSS:
Comprehensive Income Net Of Tax [Abstract]
Net loss
Holding loss, net of a tax (benefit) provision of $(973), $(706) and $130, respectively
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
COMPREHENSIVE LOSS
Comprehensive Income Net Of Tax
Tax (benefit) provision
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
This element represents receipt of Alkermes' stock for the Purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards.
This element represents receipt of Alkermes' stock for the purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards.
Statement Of Stockholders Equity [Abstract]
Equity Components
Statement Equity Components [Axis]
Equity Component
Equity Component [Domain]
Ordinary Shares
Common Stock [Member]
Additional Paid-In Capital
Additional Paid In Capital [Member]
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit
Retained Earnings [Member]
Treasury Stock
Treasury Stock [Member]
BALANCE
BALANCE (in shares)
Shares Outstanding
Issuance of ordinary shares under employee stock plans
Stock Issued During Period Value Share Based Compensation
Issuance of ordinary shares under employee stock plans (in shares)
Stock Issued During Period Shares Share Based Compensation
Receipt of Alkermes' shares for the purchase of stock options or to satisfy minimum tax withholding obligations related to share-based awards
Receipt Of Company Stock For Purchase Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
Receipt of Alkermes' shares for the purchase of stock options or to satisfy minimum tax withholding obligations related to share based awards (in shares)
Receipt Of Company Stock For Purchase Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Shares
Share-based compensation
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
Unrealized gain (loss) on marketable securities, net of tax provision (benefit)
BALANCE
BALANCE (in shares)
Tax provision (benefit)
Increase decrease in right of use asset.
Increase Decrease In Accrued sales Discount, Allowances And Reserves.
Increase decrease in operating lease liabilities.
Proceeds from contingent consideration.
Return of investment.
Payment made for licensed intellectual property.
Statement Of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Cash Provided By Used In Operating Activities [Abstract]
Net loss
Profit Loss
Adjustments to reconcile net loss to cash flows from operating activities:
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]
Depreciation and amortization
Depreciation Depletion And Amortization
Share-based compensation expense
Share Based Compensation
Deferred income taxes
Deferred Income Tax Expense Benefit
Change in the fair value of contingent consideration
Other non-cash charges
Other Noncash Expense
Changes in assets and liabilities:
Increase Decrease In Operating Capital [Abstract]
Receivables
Increase Decrease In Receivables
Contract assets
Increase Decrease In Contract With Customer Asset
Inventory
Increase Decrease In Inventories
Prepaid expenses and other assets
Increase Decrease In Prepaid Expenses Other
Right-of-use assets
Increase Decrease In Right Of Use Asset
Accounts payable and accrued expenses
Increase Decrease In Accounts Payable And Accrued Liabilities
Accrued sales discounts, allowances and reserves
Increase Decrease In Accrued Sales Discount Allowances And Reserves
Contract liabilities
Increase Decrease In Contract With Customer Liability
Operating lease liabilities
Increase Decrease In Operating Lease Liabilities
Other long-term liabilities
Increase Decrease In Other Operating Liabilities
Cash flows provided by operating activities
Net Cash Provided By Used In Operating Activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Net Cash Provided By Used In Investing Activities [Abstract]
Additions of property, plant and equipment
Payments To Acquire Property Plant And Equipment
Proceeds from the sale of equipment
Proceeds From Sale Of Property Plant And Equipment
Proceeds from contingent consideration
Proceeds From Contingent Consideration
Return of Fountain Healthcare Partners II, L.P. investment
Return Of Investments
Payment made for licensed Intellectual Property ("IP")
Payment Made For Licensed Intellectual Property
Purchases of investments
Payments To Acquire Marketable Securities
Sales and maturities of investments
Proceeds From Sale Maturity And Collections Of Investments
Cash flows used in investing activities
Net Cash Provided By Used In Investing Activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Net Cash Provided By Used In Financing Activities [Abstract]
Proceeds from the issuance of ordinary shares under share-based compensation arrangements
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
Employee taxes paid related to net share settlement of equity awards
Payments Related To Tax Withholding For Share Based Compensation
Proceeds from the issuance of long-term debt
Proceeds From Issuance Of Long Term Debt
Payment made for debt extinguishment
Payments Of Debt Extinguishment Costs
Principal payments of long-term debt
Repayments Of Long Term Debt
Cash flows (used in) provided by financing activities
Net Cash Provided By Used In Financing Activities
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CASH AND CASH EQUIVALENTS—Beginning of period
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CASH AND CASH EQUIVALENTS—End of period
SUPPLEMENTAL CASH FLOW DISCLOSURE:
Supplemental Cash Flow Information [Abstract]
Cash paid for interest
Interest Paid Net
Cash paid for taxes
Income Taxes Paid
Non-cash investing and financing activities:
Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]
Purchased capital expenditures included in accounts payable and accrued expenses
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
Documents Incorporated by Reference
Documents Incorporated By Reference [Text Block]
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Description of Business and Basis of Presentation
Business Description And Basis Of Presentation [Text Block]
Accounting Policies [Abstract]
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Revenue From Contract With Customer [Abstract]
Revenue from Contracts with Customers
Revenue From Contract With Customer [Text Block]
Investments Debt And Equity Securities [Abstract]
Investments
Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block]
Fair Value Disclosures [Abstract]
Fair Value
Fair Value Disclosures [Text Block]
Inventory Disclosure [Abstract]
Inventory
Inventory Disclosure [Text Block]
Property Plant And Equipment [Abstract]
Property, Plant and Equipment
Property Plant And Equipment Disclosure [Text Block]
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets
Goodwill And Intangible Assets Disclosure [Text Block]
Leases [Abstract]
Leases
Lessee Operating Leases [Text Block]
Payables And Accruals [Abstract]
Accounts Payable and Accrued Expenses
Accounts Payable And Accrued Liabilities Disclosure [Text Block]
Debt Disclosure [Abstract]
Long-term Debt
Long Term Debt [Text Block]
Loss Per Share
Earnings Per Share [Text Block]
Equity [Abstract]
Shareholders' Equity
Stockholders Equity Note Disclosure [Text Block]
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share-based Compensation
Disclosure Of Compensation Related Costs Share Based Payments [Text Block]
COLLABORATIVE ARRANGEMENTS
Collaborative Arrangements Disclosure [Abstract]
Collaborative Arrangements
Collaborative Arrangement Disclosure [Text Block]
Income Tax Disclosure [Abstract]
Income Taxes
Income Tax Disclosure [Text Block]
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingent Liabilities
Commitments And Contingencies Disclosure [Text Block]
Principles of Consolidation
Consolidation Policy [Text Block]
Reclassification
Prior Period Reclassification Adjustment Description
Use of Estimates
Use Of Estimates
Cash and Cash Equivalents
Cash And Cash Equivalents Policy [Text Block]
Investments
Investment Policy [Text Block]
Fair Value of Financial Instruments
Fair Value Of Financial Instruments Policy
Inventory
Inventory Policy [Text Block]
Property, Plant and Equipment
Property Plant And Equipment Policy [Text Block]
Disclosure of accounting policy for the Contingent consideration
Contingent Consideration
Contingent Consideration Policy [Text Block]
Goodwill and Intangible Assets
Goodwill And Intangible Assets Policy [Text Block]
Impairment of Long-Lived Assets
Impairment Or Disposal Of Long Lived Assets Including Intangible Assets Policy Policy [Text Block]
Revenue from Contracts with Customers
Revenue From Contract With Customer Policy [Text Block]
Receivables, net
Trade And Other Accounts Receivable Policy
Contract assets policy.
Contract Assets
Contract Assets Policy Policy [Text Block]
Contract liabilities policy.
Contract Liabilities
Contract Liabilities Policy Policy [Text Block]
Foreign Currency
Foreign Currency Transactions And Translations Policy [Text Block]
Concentrations
Concentration Risk Credit Risk
Disclosure of the entity's accounting policy for geographic information.
Geographic Information
Geographic Information Policy [Text Block]
Research and Development Expenses
Research And Development Expense Policy
Selling, General and Administrative Expenses
Selling General And Administrative Expenses Policy [Text Block]
Share-Based Compensation
Share Based Compensation Option And Incentive Plans Policy
Income Taxes
Income Tax Policy [Text Block]
Comprehensive Loss
Comprehensive Income Policy Policy [Text Block]
Loss Per Share
Earnings Per Share Policy [Text Block]
Segment Information
Segment Reporting Policy Policy [Text Block]
Employee Benefit Plans
Pension And Other Postretirement Plans Nonpension Benefits Policy
Risk and uncertainties.
Risk and Uncertainties
Risk And Uncertainties Policy [Text Block]
New Accounting Pronouncements
New Accounting Pronouncements Policy Policy [Text Block]
Tabular disclosure of the estimated useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
Schedule of Estimated Useful Life of Property, Plant and Equipment
Property Plant And Equipment Estimated Useful Lives Table [Text Block]
Schedule of Contract Assets and Contract Liabilities
Contract With Customer Asset And Liability Table [Text Block]
Schedule of Revenue and Receivables From Customers Exceeding 10% of Total in Each Category
Schedules Of Concentration Of Risk By Risk Factor [Text Block]
Schedule of Revenues by Geographic Location, as Determined by the Location of the Customer, and the Location of its Long-term Assets
Schedule Of Revenues From External Customers And Long Lived Assets By Geographical Areas Table [Text Block]
Schedule of Fair Value of Each Stock Option Grant Estimated on The Grant Date Using Weighted-average Assumptions
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]
Schedule of Disaggregation of Revenues
Disaggregation Of Revenue Table [Text Block]
Schedule of Investments
Trading Securities And Certain Trading Assets [Text Block]
Tabular disclosure of the proceeds from sales and maturities of marketable securities, plus the resulting realized gains and losses.
Schedule of Proceeds from Sales and Maturities of Marketable Securities Plus Resulting Realized Gains and Losses
Proceeds And Realized Gain Loss On Marketable Securities Table [Text Block]
Schedule of Contractual Maturities of Available-for-Sale and Held-to-Maturity Securities
Investments Classified By Contractual Maturity Date Table [Text Block]
Summary of the Company's Assets and Liabilities Measured at Fair Value on a Recurring Basis
Fair Value Assets Measured On Recurring Basis [Text Block]
Rollforward of the Fair Value of the Assets Determined using Level 3 Inputs
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Text Block]
Schedule of Inventories
Schedule Of Inventory Current Table [Text Block]
Schedule of Property, Plant and Equipment
Property Plant And Equipment [Text Block]
Schedule of Goodwill and Intangible Assets
Schedule Of Intangible Assets And Goodwill Table [Text Block]
Summary of Future Lease Payments Under Non-Cancelable Leases
Lessee Operating Lease Liability Maturity Table [Text Block]
Schedule of Accounts Payable and Accrued Expenses
Schedule Of Accounts Payable And Accrued Liabilities Table [Text Block]
Schedule of accrued sales discounts allowances and reserves.
Summary of Current Provision for Sales, Discounts, Allowances and Reserves
Schedule Of Accrued Sales Discounts Allowances And Reserves Table [Text Block]
Schedule of Long-term Debt
Schedule Of Debt Table [Text Block]
Scheduled Maturities of Term Loan Facility
Schedule Of Maturities Of Long Term Debt Table [Text Block]
Schedule of Anti-Dilutive Potential Common Share Equivalent Excluded from Calculation of Loss Per Share
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]
Award Type
Award Type [Axis]
Award Type
Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]
Represents the time-vested restricted stock units awarded by the company to its employees as a form of incentive compensation.
Time-based RSU Awards
Time Based Restricted Stock Unit Awards [Member]
Represents performance based restricted stock units as awarded by a company to their employees as a form of incentive compensation.
Performance-based RSUs Awards
Performance Based Restricted Stock Unit Awards [Member]
Schedule of Share-based Compensation Expense
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]
Schedule of Stock Option Activity
Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]
Summary of RSU Activity
Schedule Of Share Based Compensation Restricted Stock Units Award Activity Table [Text Block]
Schedule of (Benefit) Provision for Income Taxes
Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]
Tabular disclosure of net income or loss before provision for income taxes by geographical area of the entity.
Schedule of Loss Before Income Taxes by Geographical Area
Schedule Of Net Income Loss Before Provision For Taxes By Geographical Area Table [Text Block]
Schedule of Components of Net Deferred Tax Assets
Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]
Schedule of Activity in Valuation Allowance Associated with Deferred taxes
Summary Of Valuation Allowance [Text Block]
Schedule of Reconciliation of Federal Statutory Tax Rate to its Effective Tax Rate
Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]
Schedule of Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits
Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]
Schedule Of Property Plant And Equipment [Table]
Schedule Of Property Plant And Equipment [Table]
Long-Lived Tangible Asset
Property Plant And Equipment By Type [Axis]
Long-Lived Tangible Asset
Property Plant And Equipment Type [Domain]
Buildings and improvements
Building And Building Improvements [Member]
Represents furniture, fixtures and equipment of the entity.
Furniture, fixtures and equipment
Furniture Fixture And Equipment [Member]
Leasehold improvements
Leasehold Improvements [Member]
Statistical Measurement
Range [Axis]
Statistical Measurement
Range [Member]
Minimum
Minimum [Member]
Maximum
Maximum [Member]
Property Plant And Equipment [Line Items]
Property Plant And Equipment [Line Items]
Estimated useful life
Property Plant And Equipment Useful Life
Estimated useful life
Property Plant And Equipment Estimated Useful Lives
Payment terms.
Percentage of cost plus.
Summary of significant accounting policies.
Summary of significant accounting policies.
Summary Of Significant Accounting Policies [Table]
Summary Of Significant Accounting Policies [Table]
Manufacturing revenue.
Manufacturing Revenue
Manufacturing Revenue [Member]
Collaborative Arrangement and Arrangement Other than Collaborative
Type Of Arrangement [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Arrangements And Nonarrangement Transactions [Member]
Represents the information pertaining to VUMERITY.
VUMERITY
Vumerity [Member]
Balance Sheet Location
Balance Sheet Location [Axis]
Balance Sheet Location
Balance Sheet Location [Domain]
Other Assets
Other Assets [Member]
Customer
Major Customers [Axis]
Customer
Name Of Major Customer [Domain]
Biogen.
Biogen
Biogen [Member]
Time based stock options.
Time-Based Stock Options
Time Based Stock Options [Member]
Title of Individual
Title Of Individual [Axis]
Title of Individual
Title Of Individual With Relationship To Entity [Domain]
Non-employee directors.
Non-employee Directors
Non Employee Directors [Member]
Time-Based RSUs
Retirement Plan Sponsor Location
Retirement Plan Sponsor Location [Axis]
Retirement Plan Sponsor Location
Retirement Plan Sponsor Location [Domain]
Defined contribution 401 (k) plan.
401 (K) Plan
Plan401 K [Member]
Defined Contribution Plan
Foreign Plan [Member]
Summary Of Significant Accounting Policies [Line Items]
Summary Of Significant Accounting Policies [Line Items]
Payment terms in number of days
Payment Terms
Percentage of cost plus
Percentage Of Cost Plus
Unbilled receivable
Unbilled Contracts Receivable
Allowance for doubtful accounts
Contract With Customer Asset Accumulated Allowance For Credit Loss
Represents the manufacturing process period.
Consideration expects to receive month and year.
Manufacturing Process period
Manufacturing Process Period
Contract assets, current
Consideration expects to receive
Consideration Expects To Receive Month And Year
Amount of increase in contract assets due to additions during the period.
Contract Asset [Abstract]
Contract With Customer Asset Net [Abstract]
Contract assets
Contract With Customer Asset Net
Additions
Contract With Customer Asset Additions
Transferred to receivables, net
Contract With Customer Asset Reclassified To Receivable
Contract assets
Amount of increase in contract with customer liability during the period.
Contract with customer liability other (expense) income net recognized.
Contract Liabilities [Abstract]
Contract With Customer Liability [Abstract]
Contract liabilities at beginning of the period
Contract With Customer Liability
Additions
Contract With Customer Liability Additions
Amounts recognized into revenue
Contract With Customer Liability Revenue Recognized
Amounts recognized into other income, net
Contract With Customer Liability Other Expense Income Net Recognized
Contract liabilities at end of the period
Gain (loss) on foreign currency translation
Foreign Currency Transaction Gain Loss Before Tax
The minimum percentage of revenues or receivables from a single customer that is used as a threshold for disclosure of a concentration of risk.
Threshold percentage for disclosure of revenue and receivables
Threshold For Disclosure Percentage
Schedule Of Product Information [Table]
Schedule Of Product Information [Table]
Represents Janssen, a collaborative partner of the entity.
Janssen
Janssen [Member]
Cardinal Health.
Cardinal Health
Cardinal Health [Member]
AmerisourceBergen Corporation.
AmerisourceBergen
Amerisource Bergen Corporation [Member]
McKesson Corporation.
McKesson
Mc Kesson Corporation [Member]
Concentration Risk Benchmark
Concentration Risk By Benchmark [Axis]
Concentration Risk Benchmark
Concentration Risk Benchmark [Domain]
Accounts Receivable
Accounts Receivable [Member]
Aggregate revenues, net, during the period in the normal course of business.
Revenues Net
Revenues Net [Member]
Concentration Risk Type
Concentration Risk By Type [Axis]
Concentration Risk Type
Concentration Risk Type [Domain]
Credit Concentration Risk
Credit Concentration Risk [Member]
Customer Concentration Risk
Customer Concentration Risk [Member]
Product Information [Line Items]
Product Information [Line Items]
Concentration risk percentage
Concentration Risk Percentage1
Schedule Of Revenues From External Customers And Long Lived Assets [Table]
Schedule Of Revenues From External Customers And Long Lived Assets [Table]
Geographical
Statement Geographical [Axis]
Geographical
Segment Geographical [Domain]
U.S.
UNITED STATES
Ireland
IRELAND
Represents designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile, excluding the specified country.
Rest of world
Foreign Country Excluding Specified Country [Member]
Geographic Information
Revenues From External Customers And Long Lived Assets [Line Items]
Revenue by region:
Current assets:
Long-term assets:
Assets Noncurrent [Abstract]
Intangible assets
Advertising Expense
Advertising Expense
Number of equal annual installments for stock vested.
Expiration period
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
Number of equal annual installments for stock vested
Number Of Equal Annual Installments For Stock Vested
Vesting period
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted-average assumptions
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Abstract]
Expected option term
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
Expected stock volatility, minimum (as a percent)
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
Expected stock volatility, maximum (as a percent)
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
Risk-free interest rate, minimum (as a percent)
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
Risk-free interest rate, maximum (as a percent)
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
Expected annual dividend yield
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
Number of business segments
Number Of Reportable Segments
The limit of annual employee contributions to the plan, as a percentage of compensation.
The limit of annual employee contributions to the plan, as a percentage of their total taxable earnings.
Employee contribution limit as a percentage of their eligible compensation
Defined Contribution Plan Employee Contribution Limit As Percentage Of Compensation
Percentage of employer contribution matched of the first employee pay
Defined Contribution Plan Employer Matching Contribution Percent
Maximum employee contribution limit as a percentage of their total taxable earnings
Defined Contribution Plan Maximum Employee Contribution Limit As Percentage Of Taxable Earnings
Employer contribution
Defined Contribution Plan Cost Recognized
Maximum amount per employee, by the terms of the plan, that the employee may contribute to a defined contribution plan.
Per employee contribution limit
Defined Contribution Plan Annual Contribution By Per Employee Amount
Maximum percentage of employer contribution matched of employee's
Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
Disaggregation Of Revenue [Table]
Disaggregation Of Revenue [Table]
Represents the information pertaining to VIVITROL.
VIVITROL
Vivitrol [Member]
Aristada and Aristada Initio.
ARISTADA and ARISTADA INITIO
Aristada And Aristada Initio [Member]
LYBALVI.
LYBALVI
L Y B A L V I [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation Of Revenue [Line Items]
Royalty
Royalty [Member]
Long-Acting INVEGA Products.
Long-Acting INVEGA Products
Long Acting I N V E G A Products [Member]
Represents information pertaining to RISPERDAL CONSTA, a product of the entity.
RISPERDAL CONSTA
R I S P E R D A L C O N S T A [Member]
Other products and services.
Other
Other Products And Services [Member]
Arbitration award amount paid.
Potential additional award to be paid.
Repayment Of Royalty Revenue
Additional sought value for damages.
Additional award paid.
AMPYRA [Member]
AMPYRA
Ampyra [Member]
Subsequent Event Type
Subsequent Event Type [Axis]
Subsequent Event Type
Subsequent Event Type [Domain]
Subsequent Event
Subsequent Event [Member]
Royalty revenue
Potential additional award to be paid
Potential Additional Award To Be Paid
Additional award paid
Additional Award Paid
Arbitration award amount paid
Arbitration Award Amount Paid
Repayment of royalty revenue
Repayment Of Royalty Revenue
Additional sought value for damages
Additional Sought Value For Damages
Available-for-sale debt securities accumulated gross unrealized gain before tax current.
Debt securities available-for-sale continuous unrealized loss position less than 12 months accumulated loss current.
Debt securities available-for-sale continuous unrealized loss position 12 months or longer accumulated loss current.
Represents the cost of debt and equity securities, which are categorized as held-to-maturity, trading securities and available-for-sale, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
The aggregate net change in the difference between the fair value and the carrying value, or in the comparative fair values, of marketable securities categorized as trading held at each balance sheet date, that was included in earnings for the period, which may have arisen from (a) securities classified as trading, (b) the unrealized holding gain (loss) on held-to-maturity securities transferred to the trading security category, and (c) the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) on available-for-sale securities transferred to trading securities during the period.
Represents the excess of amortized cost basis over the fair value of securities that have been in a loss position for less than twelve months for those securities that are categorized as held-to-maturity, trading securities and available-for-sale.
Represents the excess of amortized cost basis over the fair value of securities that have been in a loss position for twelve months or longer for those securities that are categorized as held-to-maturity, trading securities and available-for-sale.
Represents the cost of debt and equity securities, which are categorized as long-term held-to-maturity, trading securities and available-for-sale, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
The aggregate net change in the difference between the fair value and the carrying value, or in the comparative fair values, of long term debt and equity securities held at each balance sheet date, that was included in earnings for the period.
Represents the excess of amortized cost basis over the fair value of securities that have been in a loss position for less than twelve months for those long term securities that are categorized as held-to-maturity, trading securities and available-for-sale.
Represents the excess of amortized cost basis over the fair value of securities that have been in a loss position for more than twelve months for those long term securities that are categorized as held-to-maturity, trading securities and available-for-sale.
Available-for-sale debt securities accumulated gross unrealized gain before tax noncurrent.
Debt securities available-for-sale continuous unrealized loss position less than 12 months accumulated loss noncurrent.
Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than 12 Months Accumulated Loss Non Current
Investment Holdings [Table]
Investment Holdings [Table]
Financial Instrument
Financial Instrument [Axis]
Financial Instruments
Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]
Corporate debt securities
Corporate Debt Securities [Member]
U.S. government and agency debt securities
U S Government Agencies Debt Securities [Member]
Non-U.S. government debt securities
Foreign Government Debt Securities [Member]
Cash and Cash Equivalents
Cash And Cash Equivalents [Axis]
Cash and Cash Equivalents
Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member]
Certificates of deposit
Certificates Of Deposit [Member]
Investment Holdings [Line Items]
Investment Holdings [Line Items]
Available-for-sale securities:
Available For Sale Securities [Abstract]
Short-term investments, Amortized Cost
Debt Securities Available For Sale Amortized Cost Current
Short-term investments, Gross Unrealized Gains
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Current
Short-term investments, Gross Unrealized Losses, Less than One Year
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss Current
Short-term investments, Gross Unrealized Losses, Greater than One Year
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss Current
Short-term investments, Estimated Fair Value
Long-term investments, Amortized Cost
Debt Securities Available For Sale Amortized Cost Noncurrent
Long-term investments, Unrealized Gains
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Noncurrent
Long-term investments, Gross Unrealized Losses, Less than One Year
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss Noncurrent
Long-term investments, Gross Unrealized Losses, Greater than One Year
Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than12 Months Accumulated Loss Non Current
Long-term investments, Estimated Fair Value
Available For Sale Securities Debt Securities Noncurrent
Held-to-maturity securities:
Held To Maturity Securities Parenthetical Disclosure [Abstract]
Amortized Cost
Held To Maturity Securities Amortized Cost Before Other Than Temporary Impairment
Gross Unrealized Gains
Held To Maturity Securities Accumulated Unrecognized Holding Gain
Gross Unrealized Losses Less than One Year
Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
Gross Unrealized Losses Greater than One Year
Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
Estimated Fair Value
Held To Maturity Securities Fair Value
Long-term Investments
Long Term Investments [Abstract]
Amortized Cost
Long Term Investment Amortized Cost
Gross Unrealized Gains
Long Term Investment Securities Unrealized Gain Loss
Gross Unrealized Losses, Less than One Year
Long Term Investment Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
Gross Unrealized Losses, Greater than One Year
Long Term Investment Securities Continuous Unrealized Loss Position More Than12 Months Aggregate Losses
Total long-term investments
Total investments
Marketable Securities [Abstract]
Amortized Cost
Marketable Securities At Amortized Cost
Gross Unrealized Gains
Marketable Investments Securities Unrealized Gain Loss
Gross Unrealized Losses, Less than One Year
Marketable Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
Gross Unrealized Losses, Greater than One Year
Marketable Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses
Estimated Fair Value
Investments Fair Value Disclosure
Percentage of investment securities available for sale unrealized loss position.
Number of investment securities.
Number of unrealized investment securities.
Investment, Name
Schedule Of Equity Method Investment Equity Method Investee Name [Axis]
Investment, Name
Equity Method Investee Name [Domain]
Synchronicity Pharma Inc.
Synchronicity Pharma Inc
Synchronicity Pharma Inc [Member]
Debt Instrument
Debt Instrument [Axis]
Debt Instrument, Name
Debt Instrument Name [Domain]
Convertible promissory notes.
Convertible Promissory Notes
Convertible Promissory Notes [Member]
Related Party
Related Party Transactions By Related Party [Axis]
Related Party
Related Party [Domain]
Investee
Investee [Member]
Income Statement Location
Income Statement Location [Axis]
Income Statement Location
Income Statement Location [Domain]
Other income, net
Other Operating Income Expense [Member]
Represents information pertaining to Fountain Healthcare Partners II, L.P. of Ireland ("Fountain"), created to carry on the business of investing exclusively in companies and businesses engaged in healthcare, pharmaceutical and life sciences sectors.
Fountain Healthcare Partners II
Fountain Healthcare Partners Ii Lp Of Ireland [Member]
Other Income (Expense), Net
Other Nonoperating Income Expense [Member]
Scenario
Statement Scenario [Axis]
Scenario
Scenario Unspecified [Domain]
Forecast
Scenario Forecast [Member]
Aggregate estimated fair value of investments in unrealized loss position
Debt Securities Available For Sale Unrealized Loss Position
Percentage of investment securities available for sale unrealized loss position
Percentage Of Investment Securities Available For Sale Unrealized Loss Position
Number of investment securities
Number Of Investment Securities
Number of unrealized investment securities
Number Of Unrealized Investment Securities
Purchase of convertible promissory notes
Debt Instrument Face Amount
Convertible promissory notes, maturity date
Debt Instrument Maturity Date
Equity method investment percentage
Equity Method Investment Ownership Percentage
Other-than-temporary impairment charge
Equity Method Investment Other Than Temporary Impairment
Represents the entity's total commitment, inception to date, in its equity method investment.
Represents the funding commitment expressed as a percentage of partnership's total funding.
The amount represents the commitment on the equity method investment.
Equity method commitment
Equity Method Commitment
Funding commitment as percentage of partnership's total funding
Funding Commitment As Percentage Of Partnerships Funding
Commitment on equity method investment
Commitment On Equity Method Investment
Number of portfolio sold.
Number of portfolio sold
Number Of Portfolio Sold
Proceeds from sale of portfolio
Proceeds From Sale Of Equity Method Investments
Sale of portfolio, total value
Equity Method Investment Sold Carrying Amount
Gain (loss) on investment
Income Loss From Equity Method Investments
Escrow deposit
Escrow Deposit
Carrying value of equity investment
Equity Method Investments
Represents the profit realized on the sale of debt or equity securities categorized as held-to-maturity, trading securities and available-for-sale.
Represents the loss realized on the sale of debt or equity securities categorized as held-to-maturity, trading securities and available-for-sale.
Proceeds from the sales and maturities of investments
Proceeds From Sale And Maturity Of Marketable Securities
Realized gains
Marketable Securities Realized Gain
Realized losses
Marketable Securities Realized Loss
Available-for-sale, Amortized Cost
Available For Sale Securities Debt Maturities Amortized Cost [Abstract]
Within 1 year
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
After 1 year through 5 years
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
Total
Available For Sale Debt Securities Amortized Cost Basis
Available-for-sale, Estimated Fair Value
Available For Sale Securities Debt Maturities Fair Value [Abstract]
Within 1 year
Available For Sale Securities Debt Maturities Within One Year Fair Value
After 1 year through 5 years
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
Total
Available For Sale Securities Debt Securities
Held-to-maturity, Amortized Cost
Held To Maturity Securities Debt Maturities Net Carrying Amount [Abstract]
Within 1 year
Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
After 1 year through 5 years
Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
Total
Held To Maturity Securities
Held-to-maturity, Estimated Fair Value
Held To Maturity Securities Debt Maturities Fair Value [Abstract]
Within 1 year
Held To Maturity Securities Debt Maturities Within One Year Fair Value
After 1 year through 5 years
Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
Total
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Asset Class
Fair Value By Asset Class [Axis]
Asset Class
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]
Measurement Frequency
Fair Value By Measurement Frequency [Axis]
Measurement Frequency
Fair Value Measurement Frequency [Domain]
Recurring Basis
Fair Value Measurements Recurring [Member]
Fair Value Hierarchy and NAV
Fair Value By Fair Value Hierarchy Level [Axis]
Fair Value Hierarchy and NAV
Fair Value Measurements Fair Value Hierarchy [Domain]
Level 1
Fair Value Inputs Level1 [Member]
Level 2
Fair Value Inputs Level2 [Member]
Level 3
Fair Value Inputs Level3 [Member]
Fair value
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Cash equivalents
Cash And Cash Equivalents Fair Value Disclosure
Debt securities
Contingent consideration
Business Combination Contingent Consideration Asset
Assets, Total
Assets Fair Value Disclosure
Fair value recurring basis assets or liabilities transfers between level one to level two.
Fair value recurring basis assets or liabilities transfers between level two to level one.
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table]
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table]
Counterparty Name
Counterparty Name [Axis]
Counterparty Name
Repurchase Agreement Counterparty Name [Domain]
Baudax bio, inc.
Baudax
Baudax Bio Inc [Member]
Long-Term Debt, Type
Longterm Debt Type [Axis]
Long-Term Debt, Type
Longterm Debt Type [Domain]
Twenty twenty six term loans.
2026 Term Loans
Twenty Twenty Six Term Loans [Member]
Fair Value
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Transfers between Level 1 to Level 2
Fair Value Recurring Basis Assets Or Liabilities Transfers Between Level One To Level Two
Transfers between Level 2 to Level 1
Fair Value Recurring Basis Assets Or Liabilities Transfers Between Level Two To Level One
Fair value measurement with unobservable inputs reconciliation recurring basis asset milestone and royalty payments received to contingent consideration.
Fair value measurement with unobservable inputs reconciliation recurring basis asset impairment of corporate debt security.
Balance at the beginning of the period
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
Purchase of corporate debt security
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
Change in the fair value
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]
Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List
Milestone and royalty payments received by the Company related to contingent consideration
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Milestone And Royalty Payments Received To Contingent Consideration
Impairment of corporate debt security
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Impairment Of Corporate Debt Security
Balance at the end of the period
Percentage Of Reduction In Work force
Milestone payments received.
Represents the amount of milestone payments receivable.
Percentage of reduction in work force
Percentage Of Reduction In Work Force
Milestone payments received
Milestone Payments Received
Milestone payment receivable
Milestone Payments Receivable
Increase (decrease) in fair value of contingent consideration
Amount to be realized in future
Debt Instrument Fair Value
Raw materials
Inventory Raw Materials Net Of Reserves
Work in process
Inventory Work In Process Net Of Reserves
Finished goods
Inventory Finished Goods Net Of Reserves
Total inventory
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale, located at third party warehouse and shipping service provider.
Finished goods inventory located at third-party warehouse and shipping service provider
Inventory Finished Goods Net Of Reserves Located At Third Party Warehouse And Shipping Service Provider
Land
Land [Member]
Building and Improvements
Furniture, Fixtures and Equipment
Leasehold Improvements
Construction in Progress
Construction In Progress [Member]
Property, plant and equipment
Property, plant and equipment, gross
Property Plant And Equipment Gross
Less: accumulated depreciation
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Total property, plant and equipment, net
Other Long-Term Liabilities
Other Noncurrent Liabilities [Member]
ANJESO.
ANJESO
A N J E S O [Member]
Depreciation expense
Depreciation
Carrying value at the time of disposition
Property Plant And Equipment Disposals
Construction in progress
Construction In Progress Gross
Contract with customer liability recognized through other expense income net.
Contract liabilities
Contract With Customer Liability Noncurrent
Net amounts written off into other income, net
Contract With Customer Liability Recognized Through Other Expense Income Net
Schedule Of Finite Lived Intangible Assets [Table]
Schedule Of Finite Lived Intangible Assets [Table]
Finite-Lived Intangible Assets by Major Class
Finite Lived Intangible Assets By Major Class [Axis]
Finite-Lived Intangible Assets, Major Class Name
Finite Lived Intangible Assets Major Class Name [Domain]
Collaboration agreements
Licensing Agreements [Member]
Capitalized IP
Intellectual Property [Member]
Goodwill
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount
Goodwill Gross
Net Carrying Amount
Finite-lived intangible assets:
Finite Lived Intangible Assets Net [Abstract]
Weighted Amortizable Life
Finite Lived Intangible Asset Useful Life
Gross Carrying Amount
Finite Lived Intangible Assets Gross
Accumulated Amortization
Finite Lived Intangible Assets Accumulated Amortization
Net Carrying Amount
Expected amortization of intangible assets
Finite Lived Intangible Assets Future Amortization Expense [Abstract]
2023
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
2024
Finite Lived Intangible Assets Amortization Expense Year Two
Number of significant operating leases.
Lessee Lease Description [Table]
Lessee Lease Description [Table]
900 Winter Street Lease.
900 Winter Street Lease
Winter Street Lease [Member]
Base premises.
Base Premises
Base Premises [Member]
Additional Premises.
Additional Premises
Additional Premises [Member]
Lessee Lease Description [Line Items]
Lessee Lease Description [Line Items]
Number of significant operating leases
Number Of Significant Operating Leases
Lease agreement, commencement date.
Lease agreement lease renewal term.
Operating lease expiration year.
Area of real estate property
Area Of Real Estate Property
Lease, commencement date
Lease Agreement Commencement Date
Lease agreement option to extend renewal term
Lease Agreement Lease Renewal Term
Lease, expiration year
Operating Lease Expiration Year
Increase in operating lease right of use asset.
Operating lease liability remeasurement amount.
Operating lease right of use asset remeasurement amount.
Operating lease liability remeasurement amount
Operating Lease Liability Remeasurement Amount
Operating lease right-of-use asset remeasurement amount
Operating Lease Right Of Use Asset Remeasurement Amount
Payments for operating leases
Operating Lease Payments
Increase in operating lease right of use asset
Increase In Operating Lease Right Of Use Asset
Decrease in operating lease liability
Increase Decrease In Operating Lease Liability
Represents the provision for extension of operating lease term.
Lease agreement commencement period.
Lease period
Lessee Operating Lease Term Of Contract
Lease agreement commencement period
Lease Agreement Commencement Period
Lessee operating lease term of option to extend
Operating Lease Provision For Extension Of Term
Weighted average incremental borrowing rate
Operating Lease Weighted Average Discount Rate Percent
Weighted average remaining lease term
Operating Lease Weighted Average Remaining Lease Term1
Operating lease expense
Operating Lease Expense
2023
Lessee Operating Lease Liability Payments Due Next Twelve Months
2024
Lessee Operating Lease Liability Payments Due Year Two
2025
Lessee Operating Lease Liability Payments Due Year Three
2026
Lessee Operating Lease Liability Payments Due Year Four
2027
Lessee Operating Lease Liability Payments Due Year Five
Thereafter
Lessee Operating Lease Liability Payments Due After Year Five
Total operating lease payments
Lessee Operating Lease Liability Payments Due
Less: imputed interest
Lessee Operating Lease Liability Undiscounted Excess Amount
Total operating lease liabilities
Operating Lease Liability
Accounts payable
Accounts Payable Current
Accrued compensation
Employee Related Liabilities Current
Accrued other
Other Accrued Liabilities Current
Total accounts payable and accrued expenses
Accrued sales discount allowances and reserves line items.
Accrued sales discount allowances and reserves table.
Accrued Sales Discount Allowances And Reserves [Table]
Accrued Sales Discount Allowances And Reserves [Table]
Medicaid rebate.
Medicaid Rebate
Medicaid Rebate [Member]
Product discounts.
Product Discounts
Product Discounts [Member]
Medicare Part D.
Medicare Part D
Medicare Part D [Member]
Other.
Other
Other [Member]
Accrued Sales Discount Allowances And Reserves [Line Items]
Accrued Sales Discount Allowances And Reserves [Line Items]
Total accrued sales discounts, allowances and reserves
Debt Instrument [Table]
Debt Instrument [Table]
2026 Term Loans, due March 12, 2026
Long-term debt
Debt Instrument [Line Items]
Term Loans
Long Term Debt
Less: current portion
Long-term debt
The floor for the variable rate base of the debt instrument.
Variable Rate
Variable Rate [Axis]
Variable Rate
Variable Rate [Domain]
LIBOR
London Interbank Offered Rate L I B O R [Member]
Represents the information pertaining to the 2023 Term Loans under the new term loan facility.
2023 Term Loans, due March 26, 2023
Twenty Twenty Three Term Loans [Member]
Interest Expense
Interest Expense [Member]
Due date of loan
Term loans
Variable interest rate base
Debt Instrument Description Of Variable Rate Basis
Interest rate added to base rate (as a percent)
Debt Instrument Basis Spread On Variable Rate1
Interest rate, variable interest rate floor (as a percent)
Debt Instrument Variable Rate Basis Floor
Represents the amount of incremental capacity available so long as the entity meets certain conditions.
Incremental capacity
Debt Instrument Incremental Capacity Subject To Satisfaction Of Certain Conditions
Threshold percentage of present value of remaining cash flow difference used for determining if debt terms substantially different.
Represents the number of lender holding percentage of outstanding amount.
Percentage of outstanding principal amount held by lender.
Threshold percentage comparing present value of remaining cash flows
Threshold Percentage Comparison Present Value Remaining Cash Flows
Number of lender holding percentage of outstanding amount
Number Of Lender Holding Percentage Of Outstanding Amount
Percentage of outstanding principal amount held by lender
Percentage Of Outstanding Principal Amount Held By Lender
Refinancing charges
Short Term Debt Refinanced Amount
Scheduled maturities of term loan two thousand and twenty six.
2023
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
2024
Long Term Debt Maturities Repayments Of Principal In Year Two
2025
Long Term Debt Maturities Repayments Of Principal In Year Three
2026
Long Term Debt Maturities Repayments Of Principal In Year Four
Total
Scheduled Maturities Of Term Loan Two Thousand And Twenty Six
Unamortized deferred financing costs at period end
Deferred Finance Costs Net
Original issue discount
Debt Instrument Unamortized Discount
Amortization of offering costs and discount
Amortization Of Financing Costs And Discounts
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Securities
Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]
Antidilutive Securities, Name
Antidilutive Securities Name [Domain]
Stock Options
Employee Stock Option [Member]
Restricted Stock Unit Awards
Restricted Stock Units R S U [Member]
Denominator:
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive potential common share equivalent excluded from calculation of net loss per ordinary share
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
Value of shares authorized under repurchase program
Stock Repurchase Program Authorized Amount1
Value of shares available for repurchase pursuant to repurchase program
Stock Repurchase Program Remaining Authorized Repurchase Amount1
Ordinary shares acquired under repurchase program
Treasury Stock Shares Acquired
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Cost of goods manufactured and sold
Cost Of Sales [Member]
Research and development
Research And Development Expense [Member]
Selling, general and administrative
Selling General And Administrative Expenses [Member]
Share-based compensation Expense
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total share-based compensation expense
Allocated Share Based Compensation Expense
Plan Name
Plan Name [Axis]
Plan Name
Plan Name [Domain]
Two thousand and eighteen stock option and incentive plan.
2018 Stock Option and Incentive Plan
Two Thousand And Eighteen Stock Option And Incentive Plan [Member]
Represents the 2018 Stock Option and Incentive Plan which provides for issuance of non-qualified and incentive stock options, restricted stock, restricted stock units, cash-based awards and performance shares to employees, officers and directors of, consultants to the company.
2018 Plan
Stock Option And Incentive Plan2018 [Member]
Share based compensation cost capitalized
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
Represents the number of equity-based compensation plans under which awards are currently made.
Represents the number of equity-based compensation plans under which no further awards will be made.
Number of share-based compensation plan under which awards are currently made
Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans Under Which Awards Are Currently Made
Number of share-based compensation plan under which no further awards will be made
Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans Under Which No Further Awards Will Be Made
Represents the ratio of awards other than stock options counted against the total number of shares available for issuance.
Number of increase in ordinary shares authorized for issuance thereunder
Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
Shares of common stock available for issuance
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
Ratio of awards other than stock options counted against the total number of shares available for issuance
Share Based Compensation Arrangement By Share Based Payment Award Equity Instrument Other Than Options Count Against Number Of Shares Available For Grant Ratio
Stock options
Number of Shares
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward
Outstanding at the beginning of the period (in shares)
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
Granted (in shares)
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
Exercised (in shares)
Stock Issued During Period Shares Stock Options Exercised
Expired (in shares)
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
Forfeited (in shares)
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
Outstanding at the end of the period (in shares)
Exercisable at the end of the period (in shares)
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
Weighted Average Exercise Price
Weighted Average Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price [Abstract]
Outstanding at the beginning of the period (in dollars per share)
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
Granted (in dollars per share)
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
Exercised (in dollars per share)
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
Expired (in dollars per share)
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
Forfeited (in dollars per share)
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
Outstanding at the end of the period (in dollars per share)
Exercisable at the end of the period (in dollars per share)
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
Performance-based stock options
Performance Shares [Member]
Weighted average grant-date fair value of stock options granted (in dollars per share)
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
Aggregate intrinsic value of stock options exercised
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
Stock options expected to vest (in shares)
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
Weighted average exercise price (in dollars per share)
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
Weighted average contractual remaining life
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
Aggregate intrinsic value
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
Aggregate intrinsic value of stock options exercisable
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
Weighted average remaining contractual term of stock options exercisable
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
Unrecognized compensation cost
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
Weighted average period for unrecognized compensation cost expected to be recognized
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
Outstanding stock option
Number of Shares
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward
Unvested at the beginning of the period (in shares)
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
Granted (in shares)
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
Vested (in shares)
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
Forfeited (in shares)
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
Unvested at the end of the period (in shares)
Weighted Average Grant Date Fair Value
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Roll Forward
Unvested at the beginning of the period (in dollars per share)
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
Granted (in dollars per share)
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
Vested (in dollars per share)
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
Forfeited (in dollars per share)
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
Unvested at the end of the period (in dollars per share)
Fair value of vesting RSU's
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
Number of years from the date of the grant
Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
Unrecognized compensation cost
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
Fair value of RSU's vested
Represents royalty as a percentage of net sales under the collaborative agreements.
Represents the patent royalty as a percentage of net sales under the collaborative agreements.
Represents the know-how patent royalty as a percentage of net sales under the collaborative agreements.
Represents the aggregate worldwide net sales tied to know-how royalty under the collaborative agreements.
Represents the period after the date of the first commercial sale of the product in a particular country that the agreement will expire.
Collaborative arrangement know how royalty rate resets.
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Represents information pertaining to the license agreement included under the collaboration agreement.
License agreement
License Agreement [Member]
9 O-H Risperidone Palimate.
9 O-H Risperidone Palimate [Member]
O H Risperidone Palimate [Member]
Contract with Customer, Basis of Pricing
Contract With Customer Basis Of Pricing [Axis]
Contract with Customer, Basis of Pricing
Contract With Customer Basis Of Pricing [Domain]
Represents the maximum net sales under the collaborative arrangement to determine the know how royalty percentage.
Net sales of below $250.0 million
Net Sales Below250 Million [Member]
Represents the range of net sales under the collaborative arrangement to determine the know-how royalty percentage.
Net sales between $250.0 million and 500.0 million
Net Sales Between250 And500 Million [Member]
Represents the minimum net sales under the collaborative arrangement to determine the know-how royalty percentage.
Net sales greater than $500.0 million
Net Sales Greater Than500 Million [Member]
Represents information pertaining to the manufacturing and supply agreement included under the collaboration agreement.
Manufacturing and supply agreement
Manufacturing And Supply Agreement [Member]
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Royalty rate (as a percent)
Collaborative Arrangement Royalty Rate
Patent royalty rate (as a percent)
Collaborative Arrangement Patent Royalty Rate
Know-how royalty rate (as a percent)
Collaborative Arrangement Know How Royalty Rate
Aggregate worldwide net sales
Collaborative Arrangement Net Sales Tied To Know How Royalty
Know-how royalty rate resets (as a percent)
Collaborative Arrangement Know How Royalty Rate Resets
Period after the date of the first commercial sale of the product for license expiration
Collaborative Arrangement Period After Date Of First Commercial Sale Of Product For Expiration Of Agreement
Represents the number of license agreements.
Represents the notice period required to be served before the termination of the agreement.
Represents the period for resolving default or breach after the receipt of notice for termination of agreement.
Number of license agreements
Number Of License Agreements
Notice period required to be given before termination of agreement
Collaborative Arrangement Effective Notice Period Required To Be Served For Termination Of Agreement
Period for resolving default or breach after the receipt of notice for termination of agreement
Collaborative Arrangement Period For Resolving Default Or Breach After Receipt Of Notice For Termination Of Agreement
Represents royalty rate upon termination of related agreement.
Royalty rate upon termination of manufacturing and supply agreement (as a percent)
Collaborative Arrangement Royalty Rate Upon Termination Of Related Agreement
Percentage of net sales in royalty payment.
Percentage of net sales in royalty payment
Percentage Of Net Sales In Royalty Payment
Maximum percentage of product supplies on net sales.
Maximum percentage of product supplies on net sales
Maximum Percentage Of Product Supplies On Net Sales
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Disclosures pertaining to income taxes.
Income Taxes [Table]
Income Taxes [Table]
Income Taxes [Line Items]
Income Taxes [Line Items]
Current income tax provision:
Current Income Tax Expense Benefit Continuing Operations [Abstract]
U.S. federal
Current Federal Tax Expense Benefit
U.S. state
Current State And Local Tax Expense Benefit
Rest of world
Current Foreign Tax Expense Benefit
Deferred income tax (benefit) provision:
Deferred Income Tax Expense Benefit Continuing Operations [Abstract]
U.S. federal
Deferred Federal Income Tax Expense Benefit
U.S. state
Deferred State And Local Income Tax Expense Benefit
Ireland
Deferred Foreign Income Tax Expense Benefit
Total tax (benefit) provision
Income taxes payable on repatriation of unremitted earnings.
Income Tax Authority
Income Tax Authority [Axis]
Income Tax Authority
Income Tax Authority [Domain]
U.S. state
State And Local Jurisdiction [Member]
U.S. federal
Domestic Country [Member]
Business Acquisition
Business Acquisition [Axis]
Business Acquisition, Acquiree
Business Acquisition Acquiree [Domain]
Rodin Therapeutics Incorporation.
Rodin Therapeutics Incorporation
Rodin Therapeutics Incorporation [Member]
Income Tax Authority, Name
Income Tax Authority Name [Axis]
Income Tax Authority, Name
Income Tax Authority Name [Domain]
Luxembourg inland revenue two thousand seventeen.
LTA 2017
Luxembourg Inland Revenue Two Thousand Seventeen [Member]
Luxembourg inland revenue two thousand eighteen.
LTA 2018
Luxembourg Inland Revenue Two Thousand Eighteen [Member]
Cumulative unremitted earnings of overseas subsidiaries
Undistributed Earnings Of Foreign Subsidiaries
Income taxes payable on repatriation of unremitted earnings
Income Taxes Payable On Repatriation Of Unremitted Earnings
Distribution of income (loss) before provision for income taxes
Loss before income taxes
Deferred tax assets:
Deferred Tax Assets Net [Abstract]
NOL carryforwards
Deferred Tax Assets Operating Loss Carryforwards
Research and development expenses
Deferred Tax Assets In Process Research And Development
Accrued expenses and reserves
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
Share-based compensation
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
Tax credits
Deferred Tax Assets Tax Credit Carryforwards
Other
Deferred Tax Assets Other
Less: valuation allowance
Deferred Tax Assets Valuation Allowance
Total deferred tax assets
Deferred Tax Assets Net
Deferred tax liabilities:
Deferred Tax Liabilities [Abstract]
Property, plant and equipment
Deferred Tax Liabilities Property Plant And Equipment
Other
Deferred Tax Liabilities Other
Total deferred tax liabilities
Deferred Tax Liabilities
Net deferred tax assets
Deferred Tax Assets Liabilities Net
Balance at Beginning of Period
(Additions) / Reductions
Valuation Allowances And Reserves Period Increase Decrease
Balance at End of Period
Valuation allowance
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state tax credit carryforwards.
Operating loss carryforwards
Operating Loss Carryforwards
Federal research and development credits
Deferred Tax Assets Tax Credit Carryforwards Research
State tax credits
Deferred Tax Assets Tax Credit Carryforwards State
Reconciliation of effective income tax rate
Income Tax Expense Benefit Continuing Operations Income Tax Reconciliation [Abstract]
Statutory tax rate (as a percent)
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
Loss before income taxes at statutory rate
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
Share-based compensation
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
Foreign rate differential
Income Tax Reconciliation Foreign Income Tax Rate Differential
Change in valuation allowance
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
Intercompany amounts
Effective Income Tax Reconciliation Change In Deferred Tax Assets Intercompany Amounts
Irish rate differential
Effective Income Tax Reconciliation Foreign Income Tax Differential1
Uncertain tax positions
Income Tax Reconciliation Tax Contingencies
Non-deductible lobbying expenses
Income Tax Reconciliation Nondeductible Lobbying Expenses
U.S. state income taxes, net of U.S. federal benefit
Income Tax Reconciliation State And Local Income Taxes
In-process R&D
Research And Development In Process
Foreign derived intangible income
Income Tax Reconciliation Tax Credits Foreign
R&D credit
Income Tax Reconciliation Tax Credits Research
Other permanent items
Income Tax Reconciliation Nondeductible Expense Other
Effective tax rate (as a percent)
Effective Income Tax Rate Continuing Operations
Balance at the beginning of the period
Unrecognized Tax Benefits
Reductions based on tax positions related to prior periods
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
Additions based on tax positions related to prior periods
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
Additions based on tax positions related to the current period
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
Balance at the end of the period
Represents the period after loss carryforwards have been utilized that tax returns remain open to examination.
Period after loss carryforwards utilized that tax returns remain open to examination
Period After Loss Carryforwards Utilized That Tax Returns Remain Open To Examination
Notice of Assessment
Unrecognized Tax Benefits Income Tax Penalties Expense
Commitments and contingencies.
Commitments and contingencies.
Commitments And Contingencies [Table]
Commitments And Contingencies [Table]
Janssen Pharmaceutica N.V.
Janssen Pharmaceutica N.V.
Janssen Pharmaceutica N V [Member]
Purchase Commitment, Excluding Long-Term Commitment
Purchase Commitment Excluding Longterm Commitment [Axis]
Purchase Commitment, Excluding Long-Term Commitment
Purchase Commitment Excluding Longterm Commitment [Domain]
Capital purchase commitments.
Capital Commitments
Capital Purchase Commitments [Member]
Commitments And Contingencies [Line Items]
Commitments And Contingencies [Line Items]
Potential material losses from claims, legal proceedings probable of occurring
Loss Contingency Accrual Provision
Number of license agreements partially terminated.
Number of license agreements partially terminated
Number Of License Agreements Partially Terminated
Additional sought value for damages as part of requested modification
Loss Contingency Damages Sought Value
Open purchase order commitments
Purchase Commitment Remaining Minimum Amount Committed